Remepy Competitors and Similar CompaniesClear all
Remepy's competitors and similar companies include Ardelyx and STADA.
 Ardelyx Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders. | |||
Founding Date | Founding Date 2022 | Founding Date 2007 | Founding Date 1895 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Ramat Gan, IL HQ New York, US | Locations Fremont, US HQ Waltham, US Waltham, US | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more |
Employees | Employees 479% increase | Employees 882% increase | Employees 12,33911% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) 6 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $407.3m (FY, 2025) | Revenue (est.) €3b (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods $39.5m (FY, 2025) | Cost of goods €1.3b (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit $367.8m (FY, 2025) | Gross profit €1.7b (FY, 2020) |
Net income | Net income N/A | Net income ($61.6m) (FY, 2025) | Net income €181.9m (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 10m | Total funding raised $ 61.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Ardelyx
HQ
Fremont, US
Employees
88↑ 2% increase
Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.
View company
STADA
HQ
Bad Vilbel, DE
Employees
12,339↑ 11% increase
STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.
View company